BOULDER, Colo., Aug. 31, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Wells Fargo Securities Healthcare Conference in Boston. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.

Event:

Wells Fargo Securities Healthcare Conference

Presenter:

Ron Squarer, Chief Executive Officer

Date:

Wednesday, September 7, 2016

Time:

9:50 a.m. Eastern Time

Webcast:

www.arraybiopharma.com

About Array BioPharma
 Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Five registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162), encorafenib (LGX818) and selumetinib (AstraZeneca). For more information on Array, please go to www.arraybiopharma.com.

Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-wells-fargo-securities-healthcare-conference-300315055.html

SOURCE Array BioPharma Inc.

Array BioPharma Inc. published this content on 17 September 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 17 September 2016 09:18:05 UTC.

Original documenthttp://investor.arraybiopharma.com/phoenix.zhtml?c=123810&p=irol-newsArticle&ID=2203392

Public permalinkhttp://www.publicnow.com/view/E0503A9216F2DD5A9A0C436C4F336C9F2C503F95